UK markets closed

Amphastar Pharmaceuticals, Inc. (AMPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.79+0.33 (+0.79%)
As of 10:17AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.07B
Enterprise value 2.44B
Trailing P/E 16.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.49
Price/book (mrq)3.24
Enterprise value/revenue 3.79
Enterprise value/EBITDA 10.16

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 317.13%
S&P500 52-week change 322.38%
52-week high 367.66
52-week low 336.06
50-day moving average 343.86
200-day moving average 351.29

Share statistics

Avg vol (3-month) 3415.76k
Avg vol (10-day) 3309.89k
Shares outstanding 548.87M
Implied shares outstanding 649.1M
Float 837.47M
% held by insiders 122.02%
% held by institutions 170.58%
Shares short (15 Apr 2024) 43.87M
Short ratio (15 Apr 2024) 410.56
Short % of float (15 Apr 2024) 412.06%
Short % of shares outstanding (15 Apr 2024) 47.91%
Shares short (prior month 15 Mar 2024) 43.6M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 21.34%
Operating margin (ttm)30.31%

Management effectiveness

Return on assets (ttm)11.07%
Return on equity (ttm)23.55%

Income statement

Revenue (ttm)644.4M
Revenue per share (ttm)13.35
Quarterly revenue growth (yoy)31.90%
Gross profit (ttm)N/A
EBITDA 237.72M
Net income avi to common (ttm)137.54M
Diluted EPS (ttm)2.60
Quarterly earnings growth (yoy)6.60%

Balance sheet

Total cash (mrq)256.81M
Total cash per share (mrq)5.34
Total debt (mrq)623.64M
Total debt/equity (mrq)97.53%
Current ratio (mrq)2.17
Book value per share (mrq)13.30

Cash flow statement

Operating cash flow (ttm)183.5M
Levered free cash flow (ttm)245.1M